Phase 1 Metabolic Disease Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Assess the Safety and Tolerability of SNS851 in Healthy Participants
Metabolic Disease
Oneness Biotech Co., Ltd.52 enrolled1 locationNCT07417124
Recruiting
Phase 1
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
HypercholesterolaemiaMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG90 enrolled18 locationsNCT07491172
Recruiting
Phase 1Phase 2
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Metabolic DiseaseDiabetes Mellitus, Type 1Type 1 Diabetes+14 more
Otsuka Pharmaceutical Factory, Inc.13 enrolled1 locationNCT06575426
Completed
Phase 1
A Phase 1, randomised, double-blind, placebo-controlled, parallel group study to investigate safety, tolerability and pharmacokinetics following multiple dose administration of KAI-7535 in participants with obesity and overweight
ObesityOverweightMetabolic Diseases
Kailera Therapeutics, Inc. 890 Winter Street, Suite 220 Waltham MA 0245, United States46 enrolled2 locationsACTRN12625000782437
Recruiting
Phase 1Phase 2
An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D
Diabetes MellitusMetabolic DiseaseDiabetes Mellitus, Type 1+4 more
CRISPR Therapeutics AG40 enrolled2 locationsNCT05565248